{"id":207583,"name":"ACADIA PHARMACEUTICALS","slug":"acadia-pharmaceuticals","state":"CA","country":"United States of America","description":"","totalSpending":7320000,"filings":24,"yearlySpending":[{"year":2020,"income":190000},{"year":2021,"income":840000},{"year":2022,"income":1540000},{"year":2023,"income":1040000},{"year":2024,"income":1430000},{"year":2025,"income":2280000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"MMM","display":"Medicare/Medicaid"},{"code":"BUD","display":"Budget/Appropriations"},{"code":"DEF","display":"Defense"},{"code":"TRD","display":"Trade (domestic/foreign)"},{"code":"TAX","display":"Taxation/Internal Revenue Code"}],"firms":["ACADIA PHARMACEUTICALS"],"lobbyists":["MARY REUTHER","MICHAEL MATTOON","SARAH TELLOCK"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Treasury, Dept of","Food & Drug Administration (FDA)"],"sampleDescriptions":["Issues affecting the pharmaceutical industry","Issues affecting the pharmaceutical industry","Drug pricing issues","Medicare reform; Telehealth issues","Medicare reform; Telehealth issues"]}